Antiplatelet therapy: DAPT for 3 months is sufficient

摘要

Current recommendations are to treat patients with dual antiplatelet therapy (DAPT) for 12 months after the placement of a drug-eluting stent (DES). In new data from the OPTIMIZE randomized trial, 3 months of DAPT was noninferior to 12 months of DAPT in patients with a DES. These data were presented at the Transcatheter Cardiovascular Therapeutics conference in San Francisco, CA, USA.